Results 21 to 30 of about 26,820 (222)

Effect of streptokinase in the prevention of intra-abdominal adhesions in the rat

Acta Cirúrgica Brasileira, 1997
The objective of the present study was to assess the action of streptokinase, a streptococcal derivative with fibrinolytic capacity, in the prevention of intraperitoneal adhesions in rats. Eighty animals were divided into four groups of 20 each; group A (
Benjamin Smaniotto, Maria de Lourdes Pessole Biondo-Simões, Giocondo Villanova Artigas, Antonio de Padua Gomes da Silva, Luiz Martins Collaço, Gustavo Verner Ramasco   +5 more
doaj   +1 more source

Anxiolytic and thrombolytic investigation of methanol extract of Piper nigrum L. fruits and Sesamum indicum L. seeds

Journal of Advanced Biotechnology and Experimental Therapeutics, 2020
The study was intended to compare and evaluate the in vitro thrombolytic activity and in vivo anxiolytic activities of methanol extracts of Piper nigrum fruits (MEPNF) and Sesamum indicum seeds (MESIS).
Nazim Uddin Emon, Md Kaiser, Mohammed Faisal Ibna Kabir, Mohammad Jamir Uddin, Mifta Ahmed Jyoti, Saifullah Mansur Tanjil, Abu Nayem Mohammad Rasel, Safaet Alam, Mohammad Nazmul Islam   +8 more
doaj   +1 more source

Analysis of Outcome of Intraplueral Streptokinase in Pediatric Empyema Thoracis even in Advanced Stages: A Prospective Study

Iranian Journal of Pediatrics, 2015
Background: Empyema thoracis in children causes significant morbidity. Standard treatment of Empyema thoracis includes tube drainage and antibiotics. But the tube drainage often fails.
K. Bose, S. Saha, Dhrubojyoti Mridha, Kallol Das, Piyasi Mondal, I. Das   +5 more
semanticscholar   +1 more source

A study of empyema thoracis and role of intrapleural streptokinase in its management

BMC Infectious Diseases, 2004
Background Clinical spectrum, microbiology and outcome of empyema thoracis are changing. Intrapleural instillation of fibrinolytic agents is being increasingly used for management of empyema thoracis.
Dey AB, Sharma SK, Khilnani GC, Banga Amit, Wig Naveet, Banga Namrata   +5 more
doaj   +1 more source

Safety and efficacy of streptokinase in multiloculated pleural effusion in pediatric population

Indian Journal of Respiratory Care, 2022
Introduction: Management of complicated parapneumonic effusions (CPEs) and empyema is difficult, as no clear guidelines exist. The use of intrapleural fibrinolytics has shown promising results in several studies.
Akhtar Reza, Mohd Aslam, Manju Gupta, Mohd Azam Haseen, Mayank Yadav   +4 more
doaj   +1 more source

Acute myocardial infarction associated with right bundle branch block and changeable trifascicular block: a case report

Journal of Acute Disease, 2019
Rationale: Acute myocardial infarction in the presence of right bundle branch block. Patient concerns: A 70-year-old, male heavy smoker presented with angina and hypertension.
Yasser Mohammed Hassanain Elsayed
doaj   +1 more source

Effects of Streptokinase and Normal Saline on the Incidence of Intra-abdominal Adhesion 1 Week and 1 Month after Laparotomy in Rats

Advanced Biomedical Research, 2018
Background: Intra-abdominal adhesions after surgery are usually in the form of bands and can annoy the patient throughout life causing repeated surgical procedures.
Ali Hosseini, Sima Akhavan, Maziar Menshaei, Awat Feizi   +3 more
doaj   +1 more source

Streptokinase production from Streptococcus dysgalactiae subsp. equisimilis SK-6 in the presence of surfactants, growth factors and trace elements

3 Biotech, 2014
Streptokinase is an extracellular protein secreted by various strains of streptococci and is used clinically as an intravenous thrombolytic agent for the treatment of acute myocardial infarction.
Shilpi Bhardwaj, J. Angayarkanni
semanticscholar   +1 more source

The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies

Iranian Journal of Allergy, Asthma and Immunology, 2004
The measurement of anti-streptokinase antibodies can distinguish the patients who may benefit from streptokinase and those who should be treated with some other thrombolytic regimen.
Afshin Afshari R. Elizbeth Holme
doaj  

Biosimilars: the process is the product. The example of recombinant streptokinase

Journal of Thrombosis and Haemostasis, 2014
Worldwide, streptokinase remains the most used thrombolytic agent for the treatment of myocardial infarction. Recombinant streptokinase, from E. coli, is increasingly used in developing countries as a biosimilar of native streptokinase; however, potency ...
C. Thelwell, C. Longstaff
semanticscholar   +1 more source